2Freeman ML.Nelson DB.Sherman S et al.Complications of endoscopic biliary sphincterotomy NEIM 1996:335:909-18.
3Kimmey MB.AL-Kawas FH.Carr-Locke DL.et al ASGE technology assessment status evaluation .Radiographic contrast media used in ERCP.Gastrointest Endosc 1996;43:647-51.
4Binmoeller KF Harris AG.Dumas R.et al Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?Gut 1992;33:1129-33.
5Sternlieb JM.Aronchick CA.Retig JN.et al.A.multicemer randomized controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis .Am J Gastroenterol 1992:87:1561-6.
7Arcidiacono R.Gambitta .P.Rossi A.et al .The use of a long-acting somalosiatin analogue (octreotide )for prophylasis of acute pancreatitis after endoscopic sphinclerotomy .Endoscopy 1994;26:715-8.
8Borsch G.Bergbauer M.Nebel W.et al Der Einfluss von Somatostatin auf die Amylasespiegel und Pancreatitisrale nach ERCP.Med Welt 1984;35:109-12.
9Bordas JM.Toledo V.Mondelo F.et al.Prevention of pancreatic reacions by bolus somalostin administration in patients undergoing endoscopic retrograde cholangiopancreaography and endoscopic sphinclerotomy .Hormone Res 1988;29:106-8.
10Saari A.Kivilaakso E.Shroder T.The influence of somatostatin on pancreatic imitation after pancrealography:An experimental and clinical study .Surg Res Commun 1988 :24:271-4.
同被引文献7
1Masci E, Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography:a meta-analysis. Endoscopy, 2003, 35:830 - 834.
2Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP:a meta-analysis. Gastrointest Endose, 2000, 51:1 - 7.
3Cavallini G, Tittobello A, Frulloni I, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangio pancreastography. N Eagl J Med, 1996, 335:919 - 923.
